Rixon; Mark W.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rixon; Mark W..The latest application filed is for "antibody heavy chain constant domains".
Company Profile
5.38.47
- Rixon; Mark W. - Issaquah WA
- Rixon; Mark W - Seattle WA
- Rixon; Mark W. - Seattle WA
- Rixon; Mark W. - Midland MI
Patent Activity
| Patent | Date |
|---|---|
| Antibody Heavy Chain Constant Domains App 20220185877 - Stevens; Brenda L. ; et al. | 2022-06-16 |
| Methods of treatment using IL-23p19 monoclonal antibodies Grant 11,254,740 - Stevens , et al. February 22, 2 | 2022-02-22 |
| Treating Inflammation With Soluble Hybrid Fcgamma Receptors App 20200131245 - BIRKS; Carl W. ; et al. | 2020-04-30 |
| Soluble hybrid Fc.gamma. receptors and related methods Grant 10,570,187 - Birks , et al. Feb | 2020-02-25 |
| METHODS OF TREATMENT USING IL-23p19 MONOCLONAL ANTIBODIES App 20200040072 - Stevens; Brenda L. ; et al. | 2020-02-06 |
| IL-23p19 monoclonal antibodies Grant 10,358,489 - Stevens , et al. | 2019-07-23 |
| Methods of treating inflammation with IL-17A/F and IL-23P19 bispecific antibodies Grant 10,358,490 - Stevens , et al. | 2019-07-23 |
| IL-17A/F AND IL-23p19 BISPECIFIC ANTIBODIES AND METHODS OF USING THE SAME App 20180037645 - Stevens; Brenda L. ; et al. | 2018-02-08 |
| Polynucleotides encoding IL-17/IL-23 bispecific, IL-17A/F and IL-23p19 antibodies Grant 9,783,606 - Stevens , et al. October 10, 2 | 2017-10-10 |
| IL-23p19 MONOCLONAL ANTIBODIES AND METHODS OF USING THE SAME App 20170275357 - Stevens; Brenda L. ; et al. | 2017-09-28 |
| Soluble Hybrid Fcgamma Receptors And Related Methods App 20170226184 - BIRKS; Carl W. ; et al. | 2017-08-10 |
| IL-17A/F cross-reactive monoclonal antibodies and methods of using the same Grant 9,708,401 - Stevens , et al. July 18, 2 | 2017-07-18 |
| Soluble hybrid Fc.gamma. receptors and related methods Grant 9,663,566 - Birks , et al. May 30, 2 | 2017-05-30 |
| Il-23 Antibodies And Methods Of Using The Same App 20170022272 - STEVENS; Brenda L ; et al. | 2017-01-26 |
| Methods of treating glomerulonephritis associated with IGA nephropathy for TACI-immunoglobulin fusion proteins Grant 9,346,878 - Rixon , et al. May 24, 2 | 2016-05-24 |
| Polynucleotides Encoding Antibodies App 20150099278 - Stevens; Brenda L. ; et al. | 2015-04-09 |
| Bispecific Antibodies And Methods Of Using The Same App 20150086552 - Stevens; Brenda L. ; et al. | 2015-03-26 |
| Bispecific antibodies to IL-23 and IL-17A/F Grant 8,945,553 - Stevens , et al. February 3, 2 | 2015-02-03 |
| Methods Of Use For Taci-immunoglobulin Fusion Proteins App 20140328844 - Rixon; Mark W. ; et al. | 2014-11-06 |
| Methods for Preparing TACI-immunoglobulin fusion proteins Grant 8,815,238 - Rixon , et al. August 26, 2 | 2014-08-26 |
| Soluble Hybrid Fcgamma Receptors And Related Methods App 20140107034 - BIRKS; Carl W. ; et al. | 2014-04-17 |
| Soluble hybrid Fc.gamma. receptors and related methods Grant 8,658,766 - Birks , et al. February 25, 2 | 2014-02-25 |
| Bispecific Antibodies And Methods Of Using The Same App 20130315911 - Stevens; Brenda L. ; et al. | 2013-11-28 |
| Methods For Using Taci-immunoglobulin Fusion Proteins App 20130309231 - Rixon; Mark W. ; et al. | 2013-11-21 |
| Methods of treatment using taci-immunoglobulin fusion proteins Grant 8,524,232 - Rixon , et al. September 3, 2 | 2013-09-03 |
| Soluble Interleukin-20 Receptor App 20130171130 - FOSTER; DONALD C. ; et al. | 2013-07-04 |
| Methods of treatment using anti-human IL-21 monoclonal antibodies Grant 8,361,470 - Jaspers , et al. January 29, 2 | 2013-01-29 |
| Methods Of Treating Inflammation Using Soluble Il-17ra/rc Fusion Proteins App 20120289684 - Levin; Steven D. ; et al. | 2012-11-15 |
| Anti-human Il-21 Monoclonal Antibodies App 20120225065 - JASPERS; Stephen R. ; et al. | 2012-09-06 |
| Anti-human IL-21 monoclonal antibodies Grant 8,241,629 - Jaspers , et al. August 14, 2 | 2012-08-14 |
| Methods of treating inflammation using soluble IL-17RA/RC fusion proteins Grant 8,242,072 - Levin , et al. August 14, 2 | 2012-08-14 |
| Anti-human IL-21 monoclonal antibodies Grant 8,226,948 - Jaspers , et al. July 24, 2 | 2012-07-24 |
| Anti-human Il-21 Monoclonal Antibodies App 20120177655 - JASPERS; Stephen R. ; et al. | 2012-07-12 |
| Methods of treating inflammatory disease using a soluble IL-20 receptor Grant 8,217,008 - Foster , et al. July 10, 2 | 2012-07-10 |
| Soluble Il-17ra/rc Fusion Proteins And Related Methods App 20120082668 - LEVIN; Steven D. ; et al. | 2012-04-05 |
| Anti-human IL-21 monoclonal antibodies Grant 8,124,089 - Jaspers , et al. February 28, 2 | 2012-02-28 |
| Soluble IL-17RCx4 and fusion proteins thereof Grant 8,093,355 - Kuestner , et al. January 10, 2 | 2012-01-10 |
| Soluble IL-17RA/RC fusion proteins and related methods Grant 8,084,231 - Levin , et al. December 27, 2 | 2011-12-27 |
| Methods For Using Taci-immunoglobulin Fusion Proteins App 20110229473 - Rixon; Mark W. ; et al. | 2011-09-22 |
| Soluble Hybrid Fct Receptors And Related Methods App 20110217291 - Birks; Carl W. ; et al. | 2011-09-08 |
| Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same Grant 7,964,711 - Rixon , et al. June 21, 2 | 2011-06-21 |
| Anti-human Il-21 Monoclonal Antibodies App 20110130548 - Jaspers; Stephen R. ; et al. | 2011-06-02 |
| TACI-immunoglobulin fusion proteins Grant 7,951,919 - Rixon , et al. May 31, 2 | 2011-05-31 |
| Anti-human IL-21 monoclonal antibodies Grant 7,883,700 - Jaspers , et al. February 8, 2 | 2011-02-08 |
| Soluble Interleukin-20 Receptor App 20110027263 - Foster; Donald C. ; et al. | 2011-02-03 |
| Soluble Il-17ra/rc Fusion Proteins And Related Methods App 20110014656 - LEVIN; STEVEN D. ; et al. | 2011-01-20 |
| Method of inhibiting the proliferation of B cell cancers using TACI-immunoglobulin fusion proteins Grant 7,862,814 - Rixon , et al. January 4, 2 | 2011-01-04 |
| IL-17A and IL-17F antagonists Grant 7,842,665 - Levin , et al. November 30, 2 | 2010-11-30 |
| Soluble IL-17RA/RC fusion proteins Grant 7,790,676 - Levin , et al. September 7, 2 | 2010-09-07 |
| Soluble Interleukin-20 Receptor App 20100197575 - Foster; Donald C. ; et al. | 2010-08-05 |
| Taci-immunoglobulin Fusion Proteins App 20100183609 - Rixon; Mark W. ; et al. | 2010-07-22 |
| Taci-immunoglobulin Fusion Proteins App 20100129384 - Rixon; Mark W. ; et al. | 2010-05-27 |
| Taci-immunoglobulin Fusion Proteins App 20100130728 - RIXON; MARK W. ; et al. | 2010-05-27 |
| Soluble Il-17rcx4 And Methods Of Using In Inflammation App 20100113748 - Kuestner; Rolf E. ; et al. | 2010-05-06 |
| Anti-human Il-21 Monoclonal Antibodies App 20100041873 - Jaspers; Stephen R. ; et al. | 2010-02-18 |
| Treatment Of Aplastic Anemia App 20100008917 - Hosken; Nancy ; et al. | 2010-01-14 |
| Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same Grant 7,635,767 - Rixon , et al. December 22, 2 | 2009-12-22 |
| Method of treating inflammation using soluble IL-17RCX4 Grant 7,622,116 - Kuestner , et al. November 24, 2 | 2009-11-24 |
| Soluble interleukin-20 receptor Grant 7,585,948 - Foster , et al. September 8, 2 | 2009-09-08 |
| Taci-immunoglobulin Fusion Proteins App 20090209006 - Rixon; Mark W. ; et al. | 2009-08-20 |
| Compositions And Methods For Modulating Immune Responses App 20090202534 - Levin; Steven D. ; et al. | 2009-08-13 |
| Anti-human Il-21 Monoclonal Antibodies App 20090191214 - Jaspers; Stephen R. ; et al. | 2009-07-30 |
| Il-17a And Il-17f Antagonists And Methods Of Using The Same App 20090155271 - LEVIN; STEVEN D. ; et al. | 2009-06-18 |
| TACI-immunoglobulin fusion proteins Grant 7,501,497 - Rixon , et al. March 10, 2 | 2009-03-10 |
| Soluble Il-17ra/rc Fusion Proteins And Related Methods App 20080241138 - Levin; Steven D. ; et al. | 2008-10-02 |
| Soluble interleukin-20 receptor Grant 7,387,780 - Foster , et al. June 17, 2 | 2008-06-17 |
| Compositions And Methods For Modulating Immune Responses App 20070280942 - Levin; Steven D. ; et al. | 2007-12-06 |
| Il-17a And Il-17f Antagonists And Methods Of Using The Same App 20070249533 - Levin; Steven D. ; et al. | 2007-10-25 |
| IL-17A and IL-17F Antagonists and Methods of Using the Same App 20070238658 - Levin; Steven D. ; et al. | 2007-10-11 |
| Soluble Il-17rcx4 And Methods Of Using In Inflammation App 20070196371 - Kuestner; Rolf E. ; et al. | 2007-08-23 |
| Truncated Il-17ra Soluble Receptor And Methods Of Using In Inflammation App 20070197441 - Rixon; Mark W. ; et al. | 2007-08-23 |
| Soluble Interleukin-20 Receptor App 20060263850 - Foster; Donald C. ; et al. | 2006-11-23 |
| Soluble Interleukin-20 Receptor App 20060263851 - Foster; Donald C. ; et al. | 2006-11-23 |
| Soluble Interleukin-20 receptor Grant 7,122,632 - Foster , et al. October 17, 2 | 2006-10-17 |
| TACI-immunoglobulin fusion proteins App 20060034852 - Rixon; Mark W. ; et al. | 2006-02-16 |
| Soluble interleukin-20 receptor App 20050003475 - Foster, Donald C. ; et al. | 2005-01-06 |
| Probing method for identifying antibodies specific for selected antigens Grant 6,641,999 - Mezes , et al. November 4, 2 | 2003-11-04 |
| TACI-immunoglobulin fusion proteins App 20030103986 - Rixon, Mark W. ; et al. | 2003-06-05 |
| Interferon-epsilon App 20030013162 - Conklin, Darrell C. ; et al. | 2003-01-16 |
| Family of high affinity, modified antibodies for cancer treatment Grant 5,993,813 - Mezes , et al. November 30, 1 | 1999-11-30 |
| Family of anti-carcinoembryonic antigen chimeric antibodies Grant 5,472,693 - Gourlie , et al. December 5, 1 | 1995-12-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 